Kyongbo Pharmaceutical Co., Ltd (KRX:214390)
South Korea · Delayed Price · Currency is KRW 6,090.00
+40.00 (0.66%)
Feb 20, 2026, 3:30 PM KST
Kyongbo Pharmaceutical Market Cap
Kyongbo Pharmaceutical has a market cap or net worth of 145.59 billion as of February 20, 2026. Its market cap has decreased by -9.78% in one year.
Market Cap
145.59B
Enterprise Value
265.07B
Revenue
252.20B
Ranking
n/a
PE Ratio
61.60
Stock Price
6,090.00
Market Cap Chart
Since June 29, 2015, Kyongbo Pharmaceutical's market cap has decreased from 818.81B to 145.59B, a decrease of -82.22%. That is a compound annual growth rate of -14.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 19, 2026 | 144.64B | 4.85% |
| Dec 30, 2025 | 137.94B | -7.23% |
| Dec 30, 2024 | 148.70B | -25.86% |
| Dec 28, 2023 | 200.58B | -16.10% |
| Dec 29, 2022 | 239.07B | -6.98% |
| Dec 30, 2021 | 257.00B | -34.25% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| REYON Pharmaceutical | 209.09B |
| SAMSUNG PHARM. Co., LTD. | 204.24B |
| Hana Pharm | 195.68B |
| Ilsung Is | 183.63B |
| Dongwha Pharm.Co.,Ltd | 180.17B |
| Daihan Pharmaceutical | 178.46B |
| Whan In Pharm | 168.09B |
| HANDOK | 146.67B |